American Capital Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.3K Sell
332
-1
-0.3% -$91 0.01% 275
2026
Q2
$30.5K Buy
333
+13
+4% +$1.14K 0.01% 264
2026
Q1
$27.3K Buy
320
+20
+7% +$1.78K 0.01% 261
2025
Q4
$23.7K Buy
300
+3
+1% +$235 0.01% 268
2025
Q3
$23.7K Sell
297
-5
-2% -$427 0.01% 257
2025
Q2
$27.5K Sell
302
-130
-30% -$11.9K 0.01% 234
2025
Q1
$40.5K Buy
432
+9
+2% +$806 0.02% 197
2024
Q4
$38.5K Hold
423
– – 0.02% 200
2024
Q3
$43.9K Sell
423
-61
-13% -$6.22K 0.03% 186
2024
Q2
$38.6K Sell
484
-29
-6% -$2.68K 0.03% 171
2024
Q1
$38.6K Buy
513
+29
+6% +$2.46K 0.03% 159
2023
Q4
$38.6K Buy
+484
New +$36.4K 0.03% 171

Other funds holding CL

American Capital Advisory's CL Position: Q3 2026 in Review

American Capital Advisory reduced its Colgate-Palmolive (CL) stake by 0.3% in Q3 2026, selling an estimated $91 and leaving 332 shares worth $28.3K. The position accounts for 0.01% of the portfolio, ranked #275.

American Capital Advisory first reported a position in CL in Q4 2023 and has held it in 12 quarters since. The position peaked at $43.9K in Q3 2024. 1,951 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • American Capital Advisory held 332 shares of Colgate-Palmolive worth $28.3K as of Q3 2026.
  • American Capital Advisory sold 1 Colgate-Palmolive share in Q3 2026, an estimated $91.
  • Colgate-Palmolive made up 0.01% of American Capital Advisory's portfolio in Q3 2026, its #275 holding.
  • American Capital Advisory first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 12 quarters since.
  • American Capital Advisory's Colgate-Palmolive position peaked at $43.9K in Q3 2024.
  • 1,951 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on American Capital Advisory's 13F filing for Q3 2026, filed 28 Oct 2026.